Current Clinical Research Studies for Alzheimer's Disease
If you or your loved would like to learn more about any of the following clinical research studies, please contact us and one of our study coordinators will be in touch with you.
Study 1
A Phase 2B/3, Double-blind, Randomised, Placebo-controlled 48-week Safety and Efficacy Trial of Anavex2-73 for the Treatment of Early Alzheimer’s Disease
ANAVEX2-73 is a new small molecule that has been shown in previous research studies to improve mental activities that are involved in learning, remembering and using general daily knowledge. These results may indicate that ANAVEX2-73 has protective properties on the brain neurons that are usually damaged in Alzheimer’s disease.
